IMNM has been classified into three serological subtypes: anti-signal recognition particle (SRP) myopathy, anti-3-hydroxy 3-methylglutaryl coenzyme A reductase (HMGCR) myopathy, and seronegative myopathy. This evidence concerns the gene HMGCR and myopathy.